NCT04779372

Brief Summary

This randomized, open, parallel controlled study aims to explore the clinical effectiveness of smartphone-based digital Cognitive behavioural therapy for insomnia(dCBT-I). Patients who diagnosed chronic insomnia disorder and proficient in using mobile phone intended to receive CBT-I. Participants will be random allocation into Group dCBT-I and Group Sleep Education. Primary outcome is the insomnia severity as measured using the Insomnia Severity Index (ISI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 3, 2021

Completed
21 days until next milestone

Study Start

First participant enrolled

March 24, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 6, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 6, 2022

Completed
Last Updated

December 7, 2022

Status Verified

December 1, 2022

Enrollment Period

10 months

First QC Date

February 28, 2021

Last Update Submit

December 4, 2022

Conditions

Keywords

Insomia, CBTI, Online treatment, Telemedicine, Sleep

Outcome Measures

Primary Outcomes (1)

  • Insomnia Severity Index (ISI)

    The ISI is a 6-item self-report measure of impairment in daytime functioning due to inadequate sleep. The ISI shows adequate internal consistency, appropriate test-retest reliability, and sensitivity to change with treatment. Scores can range from 0 to 28, with higher scores indicating more impairment. Scores higher than 14 are thought to be indicative of the presence of clinical insomnia and change in scores of 8.4 have been found to reflect moderate improvement in clinical samples.

    V2 and V4 visit ( 6, 18 weeks after recruitment).

Secondary Outcomes (9)

  • Sleep characters recorded by online sleep diary

    baseline, and 6, 10,18, 30 weeks after recruitment. Some participants 52 weeks after recruitment decided by themselves.

  • Sleep characters recorded by smart bracelet

    baseline, and 6, 10,18, 30 weeks after recruitment. Some participants 52 weeks after recruitment decided by themselves.

  • Dysfunctional Beliefs and Attitudes about sleep scale (DBAS-16)

    baseline, and 6, 10,18, 30 weeks after recruitment. Some participants 52 weeks after recruitment decided by themselves.

  • Fatigue Severity Scale(FSS)

    baseline, and 6, 10,18, 30 weeks after recruitment. Some participants 52 weeks after recruitment decided by themselves.

  • Health-related Quality of Life (SF-12)

    baseline, and 6, 10,18, 30 weeks after recruitment. Some participants 52 weeks after recruitment decided by themselves.

  • +4 more secondary outcomes

Study Arms (2)

Group of dCBT-I

EXPERIMENTAL

participants will receive 6-week smartphone-based dCBT-I from a Wechat applet

Behavioral: smartphone-based dCBT-I from a Wechat applet

Group of sleep education

SHAM COMPARATOR

Patients will receive sleep health education like the advices getting from common sleep clinic by the same applet as the group of CBT-I in smartphone

Behavioral: sleep education

Interventions

Participants will receive 6-week smartphone-based dCBT-I from a Wechat applet.

Group of dCBT-I
sleep educationBEHAVIORAL

Participants will receive sleep education like the advices getting from common sleep clinic.

Group of sleep education

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age≥18y;
  • Participants who meet proposed ICSD-3 and DSM-5 criterias for persistent Insomnia Disorder. (a) a current complaint of poor sleep (diffculty initiating and/or maintaining sleep, early morning wakening, or non-restorative sleep); with (b) signifcant daytime effects in 1 of 6 domains (fatigue, daytime sleepiness, cognitive impairment \[e.g., concentration problems\], mood disturbance, impaired occupational or academic functioning \[e.g., poor productivity\], impaired interpersonal/ social functioning); and (c) affecting them 3 nights per week for 3 months.
  • Insomnia Severity Index (ISI) ≥14;
  • If a comorbid sleep or psychiatric disorder is present, treatment of this condition should be stable at the time of entry in the study. There is no requirement of insomnia medications.
  • Can use APP/ Wechat applet skillfully, can freely communicate, read and fill the electronic questionnaire, well understanding.
  • Sign informed consent

You may not qualify if:

  • The presence of shift work, head injury, acute suicidality, current mania, schizophrenia or elevated substance use.
  • With documented severe physical diseases impairing sleep: such as craniocerebral disease, cancer pain, unstable angina or uncontrolled heart failure, etc.
  • Current or past CBT-I
  • Epworth Sleepiness Scale (ESS) ≥12
  • Without informed consent or not signed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University First Hospital

Beijing, Beijing Municipality, 100034, China

Location

Related Publications (1)

  • Zhang C, Liu Y, Guo X, Liu Y, Shen Y, Ma J. Digital Cognitive Behavioral Therapy for Insomnia Using a Smartphone Application in China: A Pilot Randomized Clinical Trial. JAMA Netw Open. 2023 Mar 1;6(3):e234866. doi: 10.1001/jamanetworkopen.2023.4866.

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Jing Ma, Doctor

    Peking University First Hospital

    STUDY CHAIR
  • Cheng Zhang, Doctor

    Peking University First Hospital

    STUDY DIRECTOR
  • Yanan Liu, Doctor

    Peking University First Hospital

    STUDY DIRECTOR
  • Yane Shen, Postgraduate

    Peking University First Hospital

    STUDY DIRECTOR
  • Xiaoming Guo, Doctor

    Peking University First Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be random allocation into two groups named Group dCBT-I and Group Sleep Education.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

February 28, 2021

First Posted

March 3, 2021

Study Start

March 24, 2021

Primary Completion

January 6, 2022

Study Completion

July 6, 2022

Last Updated

December 7, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations